Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07268963

Biofeedback for Dysfunctional Voiding and Giggle Incontinence

This study aims to evaluate the efficacy of biofeedback treatment for dysfunctional voiding and giggle incontinence in children. Predictive factors of treatment success will also researched.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Biofeedback Therapy Dysfunctional Voiding Giggle Incontinence

Age range

4 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital

Istanbul, Kadikoy, 34000, Turkey (Türkiye)

About this study

A total of approximately 60 patients who received biofeedback therapy will be evaluated retrospectively. Treatment success rates among these patients will be evaluated. Patients will be divided into mainly two groups according to the diagnosis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with dysfunctional voiding or giggle incontinence
  • Patients treated with biofeedback therapy

Exclusion criteria

  • Presence of anatomical or neurological problems
  • Patients with missing data

Treatment and study plan

biofeedback therapy

Behavioral

Biofeedback therapy is a behavioral treatment method that helps patients become more aware of and gain better control over their pelvic floor muscles. Using EMG electrodes, muscle activity is monitored and presented to the patient visually or audibly, enabling them to recognize and correct improper muscle contractions or relaxations that contribute to urinary incontinence.

Primary outcomes

  1. Number of Participants with Biofeedback-Related Resolution

    Time frame: From enrollment to the end of treatment at 18 weeks

    Participants achieved a complete response which means 100% improvement in resolution of incontinence and abnormal voiding pattern

Other outcomes

  1. Predictive Factors of Treatment Response

    Time frame: 18 weeks

    Age, gender, and diagnosis will be evaluated as potential predictive factors of treatment response

Sponsors and collaborators

Lead sponsor

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Other

Registry information

Official study title

Biofeedback for Dysfunctional Voiding and Giggle Incontinence in Children

Important dates

Study start
2022
Primary completion
2025
Study completion
2026
First posted
Dec 8, 2025
Registry last updated
Dec 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.